Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Giuliani S.p.A. is a privately held Italian pharmaceutical company with a long-standing history of innovation in gastroenterology, dermatology, and trichology. Founded in 1889 and headquartered in Milan, the company focuses on the 'gut-skin axis' and the therapeutic potential of the human microbiome. Giuliani develops and markets a diverse portfolio ranging from prescription pharmaceuticals for inflammatory bowel disease to market-leading consumer brands like Bioscalin for hair health and Lichtena for skin care. Their R&D pipeline includes novel small molecules such as P2X7 receptor antagonists and microbiome-modulating agents, often advanced through strategic international partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Giuliani Partners.